A Study to Evaluate the Safety, Antiviral Effect, and Pharmacokinetics of Celgosivir in Combination With Peginterferon Alfa-2b and Ribavirin in Treatment-Naïve Patients With Chronic Hepatitis C
The recruitment status of this study is unknown because the information has not been verified recently.
Verified April 2008 by BioWest Therapeutics Inc.
Recruitment status was Recruiting
Recruitment status was Recruiting
Sponsor:
BioWest Therapeutics Inc
Information provided by:
BioWest Therapeutics Inc
ClinicalTrials.gov Identifier:
NCT00332176
First received: May 30, 2006
Last updated: April 3, 2008
Last verified: April 2008
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is currently recruiting participants. |
|---|---|
| Estimated Study Completion Date: | December 2008 |
| Estimated Primary Completion Date: | December 2008 (Final data collection date for primary outcome measure) |